デフォルト表紙
市場調査レポート
商品コード
1539591

人工肺の世界市場レポート 2024年

Artificial Lung Global Market Report 2024

出版日: | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=149.25円
人工肺の世界市場レポート 2024年
出版日: 2024年08月21日
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2~10営業日
ご注意事項 :
本レポートの納品は、最新情報反映のため受注時に適宜更新しお届けいたします。
更新情報の反映作業にあたり納期もレポート毎に異なりますので、ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

人工肺市場規模は、今後数年で急成長が見込まれます。2028年にはCAGR12.0%で36億3,000万米ドルに成長します。予測期間における成長の要因としては、呼吸器疾患の有病率の増加、医療施設の進歩、低侵襲手技の受け入れ拡大、患者のQOL向上、慢性閉塞性肺疾患の増加が挙げられます。この期間に予想される主要動向には、ワイヤレス技術の統合、人工知能(AI)の採用、ゲノミクスと医療技術の進歩、より小型で持ち運び可能な人工肺の開発などがあります。

人工肺市場は、呼吸器疾患の有病率の増加によって成長が見込まれます。この増加は、大気汚染の深刻化、気候変動、ライフスタイルの変化などの要因に影響され、公衆衛生に大きな負担を強いています。人工肺は、酸素供給を行い、血液から二酸化炭素を除去し、損なわれた肺機能をサポートまたは代替することにより、呼吸器疾患の治療において重要な役割を果たしています。例えば、オーストラリア保健福祉研究所が2024年6月に報告したように、オーストラリアでは人口の34%を占める約850万人が慢性呼吸器疾患を患っていると推定されています。その内訳は、喘息が280万人(人口の11%)、慢性閉塞性肺疾患(COPD)が63万8,000人(人口の2.5%)です。このように、呼吸器疾患の有病率の増加は、人工肺市場拡大の重要な促進要因となっています。

人工肺市場の新興国市場開拓企業は、患者ケアと治療成績向上のため、革新的なソリューション、特に呼吸支援システムを積極的に開発しています。呼吸支援システムは、患者の呼吸を補助または維持するために設計された医療機器です。例えば、米国を拠点とするALung Technologies Inc.は2021年12月、同社のHemolung呼吸支援システムに関して米国食品医薬品局から承認を取得しました。この装置は、呼吸補助に適応された最初で唯一の体外式二酸化炭素除去(ECCO2R)装置であり、他の換気方法が不十分または安全でなく、臨床的悪化が予想される場合に、急性で可逆性の呼吸不全の成人に最大5日間、患者の血液から二酸化炭素を除去します。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界の市場規模と成長

  • 世界の人工肺市場:促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の人工肺市場の実績:規模と成長、2018~2023年
  • 世界の人工肺市場の予測:規模と成長、2023~2028年、2033年

第6章 市場セグメンテーション

  • 世界の人工肺市場:製品タイプ別、実績と予測、2018~2023年、2023~2028年、2033年
  • シングルローラーポンプ
  • ダブルローラーポンプ
  • バブル
  • 世界の人工肺市場:用途別、実績と予測、2018~2023年、2023~2028年、2033年
  • 心臓手術
  • 肺移植手術
  • 急性呼吸不全の治療
  • その他
  • 世界の人工肺市場:エンドユーザー別、実績と予測、2018~2023年、2023~2028年、2033年
  • 病院
  • 救急センター
  • その他

第7章 地域別・国別分析

  • 世界の人工肺市場:地域別、実績と予測、2018~2023年、2023~2028年、2033年
  • 世界の人工肺市場:国別、実績と予測、2018~2023年、2023~2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 人工肺市場:競合情勢
  • 人工肺市場:企業プロファイル
    • Terumo Corporation
    • Getinge AB
    • Abiomed Inc.
    • MicroPort Scientific Corp.
    • Charles Stark Draper Laboratory Inc.

第31章 その他の大手企業と革新的企業

  • TransMedics Group Inc.
  • Braile Biomedica Ltd.
  • Xenios AG
  • MC3 Cardiopulmonary Inc.
  • Lung Biotechnology PBC
  • Breethe Inc.
  • Levitronix LLC
  • Medos Medizintechnik AG
  • ALung Technologies Inc.
  • McGowan Institute for Regenerative Medicine
  • Hemovent GmbH
  • Novalung GmbH
  • Haemair Ltd.
  • MedArray Inc.
  • Vivonics Inc.

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の展望と潜在的な分析

第36章 付録

目次
Product Code: r19030

An artificial lung is a medical device created to assume the function of natural lungs by supplying oxygen to the blood and eliminating carbon dioxide. It is commonly employed in patients experiencing severe respiratory failure or during surgeries where temporary cessation of heart and lung function is necessary. This technology aims to support or replace lung function, facilitating patient survival and recovery from critical conditions.

The primary types of artificial lungs include single roller pump heart-lung machines, double roller pump heart-lung machines, bubble artificial lungs, and membrane artificial lungs. A single roller pump heart-lung machine operates using a single roller pump to circulate blood through an artificial lung and back into the patient during cardiopulmonary bypass surgery. These machines are utilized in cardiac surgery, lung transplants, acute respiratory failure treatments, and other medical procedures, catering to diverse end users such as hospitals, emergency centers, and healthcare facilities.

The artificial lung research report is one of a series of new reports from The Business Research Company that provides artificial lung market statistics, including the artificial lung industry's global market size, regional shares, competitors with an artificial lung market share, detailed artificial lung market segments, market trends and opportunities, and any further data you may need to thrive in the artificial lung industry. This artificial lung market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The artificial lung market size has grown rapidly in recent years. It will grow from $2.06 billion in 2023 to $2.31 billion in 2024 at a compound annual growth rate (CAGR) of 11.9%. During the historic period, growth can be attributed to several factors including heightened awareness among healthcare professionals, expanding market penetration, increased adoption in home care settings, the growth of medical tourism, and advancements in healthcare infrastructure.

The artificial lung market size is expected to see rapid growth in the next few years. It will grow to $3.63 billion in 2028 at a compound annual growth rate (CAGR) of 12.0%. In the forecast period, growth can be attributed to the increasing prevalence of respiratory diseases, advancements in healthcare facilities, greater acceptance of minimally invasive procedures, improved patient quality of life, and a rise in chronic obstructive pulmonary diseases. Key trends expected in this period include the integration of wireless technology, adoption of artificial intelligence (AI), advancements in genomics and medical technology, and the development of smaller, more portable artificial lungs.

The artificial lung market is expected to experience growth driven by the increasing prevalence of respiratory diseases. This rise is influenced by factors such as escalating air pollution, climate changes, and shifts in lifestyle, placing a substantial burden on public health. Artificial lungs play a critical role in treating respiratory conditions by providing oxygenation and removing carbon dioxide from the blood, supporting or replacing impaired lung function. For example, as reported by the Australian Institute of Health and Welfare in June 2024, approximately 8.5 million people in Australia, constituting 34% of the population, were estimated to have chronic respiratory conditions. This includes 2.8 million people (11% of the population) with asthma and 638,000 people (2.5% of the population) with chronic obstructive pulmonary disease (COPD). Thus, the growing prevalence of respiratory diseases is a key driver behind the expansion of the artificial lung market.

Leading companies in the artificial lung market are actively developing innovative solutions, particularly respiratory support systems, to enhance patient care and outcomes. Respiratory support systems are medical devices designed to assist or maintain a patient's breathing. For instance, in December 2021, ALung Technologies Inc., based in the US, obtained approval from the US Food and Drug Administration for its Hemolung Respiratory Support System. This device is the first and only extracorporeal carbon dioxide removal (ECCO2R) device indicated for respiratory support, providing CO2 removal from the patient's blood for up to 5 days in adults with acute, reversible respiratory failure when other ventilation methods are inadequate or unsafe, and clinical deterioration is anticipated.

In May 2022, LivaNova plc, a UK-based medical device company, acquired ALung Technologies to bolster its portfolio in advanced respiratory therapies. This acquisition aimed to strengthen LivaNova's capability to deliver innovative solutions for respiratory support, particularly focusing on advancing artificial lung technologies. ALung Technologies, headquartered in the US, specializes in developing intra- and extracorporeal gas exchange devices for treating acute and chronic respiratory disorders.

Major companies operating in the artificial lung market are Terumo Corporation, Getinge AB, Abiomed Inc., MicroPort Scientific Corp., Charles Stark Draper Laboratory Inc., TransMedics Group Inc., Braile Biomedica Ltd., Xenios AG, MC3 Cardiopulmonary Inc., Lung Biotechnology PBC, Breethe Inc., Levitronix LLC, Medos Medizintechnik AG, ALung Technologies Inc., McGowan Institute for Regenerative Medicine, Hemovent GmbH, Novalung GmbH, Haemair Ltd., MedArray Inc., Vivonics Inc., Extracorporeal Life Support (ECLS) Lab

North America was the largest region in the artificial lung market in 2023. The regions covered in the artificial lung market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the artificial lung market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The artificial lung market consists of sales of extracorporeal membrane oxygenation (ECMO), intravenous membrane oxygenators (IVOX), bioartificial lungs, and microfluidic artificial lungs. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Artificial Lung Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on artificial lung market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for artificial lung ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The artificial lung market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product Type: Single Roller Pump Heart Lung Machines; Double Roller Pump Heart Lungs Machines; Bubble Artificial Lung; Membrane Artificial Lung
  • 2) By Application: Cardiac Surgery; Lung Transplant Operation; Acute Respiratory Failure Treatment; Other Applications
  • 3) By End-Users: Hospital; Emergency Center; Other End-users
  • Companies Mentioned: Terumo Corporation; Getinge AB; Abiomed Inc.; MicroPort Scientific Corp.; Charles Stark Draper Laboratory Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Artificial Lung Market Characteristics

3. Artificial Lung Market Trends And Strategies

4. Artificial Lung Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Artificial Lung Market Size and Growth

  • 5.1. Global Artificial Lung Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Artificial Lung Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Artificial Lung Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Artificial Lung Market Segmentation

  • 6.1. Global Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Single Roller Pump Heart Lung Machines
  • Double Roller Pump Heart Lungs Machines
  • Bubble Artificial Lung
  • Membrane Artificial Lung
  • 6.2. Global Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Cardiac Surgery
  • Lung Transplant Operation
  • Acute Respiratory Failure Treatment
  • Other Applications
  • 6.3. Global Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospital
  • Emergency Center
  • Other End-user

7. Artificial Lung Market Regional And Country Analysis

  • 7.1. Global Artificial Lung Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Artificial Lung Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Artificial Lung Market

  • 8.1. Asia-Pacific Artificial Lung Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Artificial Lung Market

  • 9.1. China Artificial Lung Market Overview
  • 9.2. China Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Artificial Lung Market

  • 10.1. India Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Artificial Lung Market

  • 11.1. Japan Artificial Lung Market Overview
  • 11.2. Japan Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Artificial Lung Market

  • 12.1. Australia Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Artificial Lung Market

  • 13.1. Indonesia Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Artificial Lung Market

  • 14.1. South Korea Artificial Lung Market Overview
  • 14.2. South Korea Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Artificial Lung Market

  • 15.1. Western Europe Artificial Lung Market Overview
  • 15.2. Western Europe Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Artificial Lung Market

  • 16.1. UK Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Artificial Lung Market

  • 17.1. Germany Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Artificial Lung Market

  • 18.1. France Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Artificial Lung Market

  • 19.1. Italy Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Artificial Lung Market

  • 20.1. Spain Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Artificial Lung Market

  • 21.1. Eastern Europe Artificial Lung Market Overview
  • 21.2. Eastern Europe Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Artificial Lung Market

  • 22.1. Russia Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Artificial Lung Market

  • 23.1. North America Artificial Lung Market Overview
  • 23.2. North America Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Artificial Lung Market

  • 24.1. USA Artificial Lung Market Overview
  • 24.2. USA Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Artificial Lung Market

  • 25.1. Canada Artificial Lung Market Overview
  • 25.2. Canada Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Artificial Lung Market

  • 26.1. South America Artificial Lung Market Overview
  • 26.2. South America Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Artificial Lung Market

  • 27.1. Brazil Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Artificial Lung Market

  • 28.1. Middle East Artificial Lung Market Overview
  • 28.2. Middle East Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Artificial Lung Market

  • 29.1. Africa Artificial Lung Market Overview
  • 29.2. Africa Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Artificial Lung Market Competitive Landscape And Company Profiles

  • 30.1. Artificial Lung Market Competitive Landscape
  • 30.2. Artificial Lung Market Company Profiles
    • 30.2.1. Terumo Corporation
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Getinge AB
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Abiomed Inc.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. MicroPort Scientific Corp.
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Charles Stark Draper Laboratory Inc.
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Artificial Lung Market Other Major And Innovative Companies

  • 31.1. TransMedics Group Inc.
  • 31.2. Braile Biomedica Ltd.
  • 31.3. Xenios AG
  • 31.4. MC3 Cardiopulmonary Inc.
  • 31.5. Lung Biotechnology PBC
  • 31.6. Breethe Inc.
  • 31.7. Levitronix LLC
  • 31.8. Medos Medizintechnik AG
  • 31.9. ALung Technologies Inc.
  • 31.10. McGowan Institute for Regenerative Medicine
  • 31.11. Hemovent GmbH
  • 31.12. Novalung GmbH
  • 31.13. Haemair Ltd.
  • 31.14. MedArray Inc.
  • 31.15. Vivonics Inc.

32. Global Artificial Lung Market Competitive Benchmarking

33. Global Artificial Lung Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Artificial Lung Market

35. Artificial Lung Market Future Outlook and Potential Analysis

  • 35.1 Artificial Lung Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Artificial Lung Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Artificial Lung Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer